A Phase I-II Study: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK, After Transplantation of Allogeneic T-Depleted Stem Cells From a Haploidentical Donor in Patients With Haematological Malignancies.

Trial Profile

A Phase I-II Study: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK, After Transplantation of Allogeneic T-Depleted Stem Cells From a Haploidentical Donor in Patients With Haematological Malignancies.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs TK (Primary)
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Lymphoma; Multiple myeloma
  • Focus Therapeutic Use
  • Sponsors MolMed
  • Most Recent Events

    • 06 Dec 2016 Pooled results from this and other phase III study (profile 700030106) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
    • 05 Dec 2016 Results published in the MolMed Media Release.
    • 05 Dec 2016 According to a MolMed media release, data from this trial is summarised during a symposium at the 1st EBMT International Transplant Course.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top